InsiderTrades.com logo
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

IOVA Insider Trading

Insider Ownership Percentage: 10.40%
Insider Buying (Last 12 Months): $28,843,100.00
Insider Selling (Last 12 Months): $0.00

Iovance Biotherapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Iovance Biotherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Iovance Biotherapeutics Share Price & Price History

Current Price: $11.24
Price Change: ▼ Price Decrease of -0.47 (-4.01%)
As of 04/25/2024 10:40 AM ET

This chart shows the closing price history over time for IOVA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

Iovance Biotherapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/20/2024Merrill A McpeakDirectorBuy250,000$9.15$2,287,500.00320,150View SEC Filing Icon  
9/18/2023Merrill A McpeakDirectorBuy10,000$5.56$55,600.00248,633View SEC Filing Icon  
9/15/2023Wayne P RothbaumDirectorBuy5,000,000$5.30$26,500,000.0023,067,333View SEC Filing Icon  
12/21/2022Merrill A McpeakDirectorBuy10,000$6.15$61,500.0070,150View SEC Filing Icon  
12/2/2022Wayne P RothbaumDirectorBuy10,000,000$6.50$65,000,000.0018,067,333View SEC Filing Icon  
11/28/2022Frederick G VogtCEOBuy1,000$5.98$5,980.002,000View SEC Filing Icon  
11/28/2022Merrill A McpeakDirectorBuy10,000$6.18$61,800.00228,633View SEC Filing Icon  
11/23/2022Iain D DukesDirectorBuy10,000$6.10$61,000.0022,000View SEC Filing Icon  
6/1/2022Frederick G VogtCEOBuy1,000$6.44$6,440.001,000View SEC Filing Icon  
5/31/2022Merrill A McpeakDirectorBuy10,000$6.84$68,400.0020,150View SEC Filing Icon  
See Full Table
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

SEC Filings (Institutional Ownership Changes) for Iovance Biotherapeutics (NASDAQ:IOVA)

77.03% of Iovance Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IOVA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Iovance Biotherapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/23/2024Rice Hall James & Associates LLC1,713,825$25.40M1.5%-2.1%0.614%Search for SEC Filing on Google Icon
4/23/2024Raymond James Financial Services Advisors Inc.136,754$2.03M0.0%+5.0%0.049%Search for SEC Filing on Google Icon
4/18/2024Diversified Trust Co15,511$0.23M0.0%+14.8%0.006%Search for SEC Filing on Google Icon
4/17/2024Grimes & Company Inc.29,250$0.43M0.0%-16.4%0.010%Search for SEC Filing on Google Icon
4/17/2024Hennion & Walsh Asset Management Inc.407,429$6.04M0.3%+42.4%0.146%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.22,812,820$185.47M0.0%+3.0%8.168%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.3,681,560$29.93M0.0%-2.2%1.439%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC11,979,415$97.39M2.2%+0.1%4.681%Search for SEC Filing on Google Icon
2/23/2024Chicago Partners Investment Group LLC20,559$0.16M0.0%+15.0%0.008%Search for SEC Filing on Google Icon
2/15/2024Opaleye Management Inc.897,000$7.29M2.0%+47.0%0.351%Search for SEC Filing on Google Icon
2/15/2024Boxer Capital LLC1,400,000$11.38M0.6%-62.2%0.547%Search for SEC Filing on Google Icon
2/15/2024Brevan Howard Capital Management LP692,775$5.63M0.1%-55.7%0.271%Search for SEC Filing on Google Icon
2/14/2024Invenomic Capital Management LP1,053,251$8.56M0.4%N/A0.412%Search for SEC Filing on Google Icon
2/14/2024Pale Fire Capital SE17,024$0.14M0.0%+12.7%0.007%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.198,800$1.62M0.7%-79.8%0.078%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC1,247,515$10.14M0.0%-16.6%0.487%Search for SEC Filing on Google Icon
2/13/2024Rhenman & Partners Asset Management AB1,116,818$9.08M0.9%+17.6%0.436%Search for SEC Filing on Google Icon
2/12/2024Eagle Asset Management Inc.450,456$3.66M0.0%N/A0.176%Search for SEC Filing on Google Icon
2/12/2024Capstone Investment Advisors LLC20,785$0.17M0.0%-27.1%0.008%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc257,460$2.09M0.0%-23.4%0.101%Search for SEC Filing on Google Icon
2/12/2024Artisan Partners Limited Partnership4,827,670$39.25M0.1%-4.1%1.886%Search for SEC Filing on Google Icon
2/12/2024Pier 88 Investment Partners LLC27,290$0.22M0.1%N/A0.011%Search for SEC Filing on Google Icon
2/9/2024Corient Private Wealth LLC367,000$2.98M0.0%+206.3%0.143%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG857,308$6.97M0.0%+255.2%0.335%Search for SEC Filing on Google Icon
2/9/2024Norges Bank1,120,457$9.11M0.0%N/A0.438%Search for SEC Filing on Google Icon
2/8/2024Roanoke Asset Management Corp NY41,140$0.33M0.1%+16.5%0.016%Search for SEC Filing on Google Icon
2/8/2024Great Lakes Advisors LLC136,183$1.11M0.0%-50.8%0.053%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.346,190$2.82M0.0%+3.7%0.135%Search for SEC Filing on Google Icon
2/8/2024Quadrant Capital Group LLC5,059$41K0.0%+1,227.8%0.002%Search for SEC Filing on Google Icon
2/8/2024Inceptionr LLC13,266$0.11M0.1%N/A0.005%Search for SEC Filing on Google Icon
2/8/2024Vanguard Personalized Indexing Management LLC15,407$0.13M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/8/2024Mitsubishi UFJ Asset Management Co. Ltd.44,765$0.35M0.0%+19.4%0.017%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.2,636,327$21.43M0.0%-0.3%1.030%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP3,516,987$28.60M0.0%-11.6%1.374%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets552,847$4.50M0.0%+83.5%0.216%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas51,598$0.42M0.0%-18.5%0.020%Search for SEC Filing on Google Icon
2/7/2024Calton & Associates Inc.12,090$98K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.66,738$0.54M0.0%-13.2%0.026%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.1,747,023$14.20M0.0%+3.2%0.683%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank20,936$0.17M0.0%-6.1%0.008%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank439,456$3.57M0.0%-10.2%0.172%Search for SEC Filing on Google Icon
2/6/2024New York Life Investment Management LLC56,959$0.46M0.0%-2.3%0.022%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.26,921$0.22M0.0%+19.1%0.011%Search for SEC Filing on Google Icon
2/5/2024Pekin Hardy Strauss Inc.53,000$0.43M0.1%-5.4%0.021%Search for SEC Filing on Google Icon
2/5/2024Intellectus Partners LLC116,679$0.95M0.3%-3.0%0.046%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.8,035$65K0.0%-39.7%0.003%Search for SEC Filing on Google Icon
2/2/2024Parametrica Management Ltd320,276$2.60M4.3%+235.7%0.125%Search for SEC Filing on Google Icon
2/2/2024Bailard Inc.12,700$0.10M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund1,021,824$8.31M0.0%-0.5%0.399%Search for SEC Filing on Google Icon
2/1/2024Jennison Associates LLC91,155$0.74M0.0%N/A0.036%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB55,700$0.45M0.0%+90.8%0.022%Search for SEC Filing on Google Icon
2/1/2024Signaturefd LLC8,723$71K0.0%+256.6%0.003%Search for SEC Filing on Google Icon
1/31/2024J.W. Cole Advisors Inc.62,292$0.51M0.0%N/A0.024%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank 44,145$0.36M0.0%+13.2%0.017%Search for SEC Filing on Google Icon
1/30/2024Carnegie Capital Asset Management LLC27,400$0.22M0.0%+17.1%0.011%Search for SEC Filing on Google Icon
1/25/2024Nisa Investment Advisors LLC7,541$61K0.0%+284.0%0.003%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.142,946$1.16M0.0%-3.4%0.056%Search for SEC Filing on Google Icon
1/24/2024Grimes & Company Inc.34,998$0.29M0.0%+136.9%0.014%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.29,602$0.24M0.0%+365.7%0.012%Search for SEC Filing on Google Icon
1/23/2024Dumont & Blake Investment Advisors LLC11,500$93K0.0%N/A0.004%Search for SEC Filing on Google Icon
1/18/2024Clear Harbor Asset Management LLC11,000$89K0.0%N/A0.004%Search for SEC Filing on Google Icon
1/16/2024Raymond James Financial Services Advisors Inc.130,287$1.06M0.0%+48.7%0.051%Search for SEC Filing on Google Icon
1/16/2024Raymond James & Associates16,910$0.14M0.0%+29.7%0.007%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC88,729$0.72M0.0%-67.9%0.035%Search for SEC Filing on Google Icon
1/8/2024Diversified Trust Co13,512$0.11M0.0%+12.3%0.005%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC26,603$0.22M0.0%+34.0%0.010%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.22,143,470$100.75M0.0%+8.6%8.652%Search for SEC Filing on Google Icon
12/7/2023Hudson Bay Capital Management LP430,200$1.96M0.0%+56.4%0.168%Search for SEC Filing on Google Icon
11/27/2023Banque Pictet & Cie SA633,794$2.88M0.0%+18.7%0.248%Search for SEC Filing on Google Icon
11/15/2023Annandale Capital LLC7,000$32K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/15/2023Sectoral Asset Management Inc.985,000$4.48M0.9%N/A0.385%Search for SEC Filing on Google Icon
11/15/2023Seven Eight Capital LP319,502$1.45M0.2%+141.6%0.125%Search for SEC Filing on Google Icon
11/15/2023Kennedy Capital Management LLC344,042$1.57M0.0%+52.3%0.134%Search for SEC Filing on Google Icon
11/15/2023Kettle Hill Capital Management LLC38,474$0.18M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/15/2023AXQ Capital LP21,700$99K0.0%N/A0.008%Search for SEC Filing on Google Icon
11/14/2023MPM Bioimpact LLC3,287,397$14.96M4.0%+11.4%1.285%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC250,510$1.14M0.1%+31.1%0.098%Search for SEC Filing on Google Icon
11/14/2023Pale Fire Capital SE15,100$69K0.0%N/A0.006%Search for SEC Filing on Google Icon
11/13/2023Portland Investment Counsel Inc.15,000$68K0.0%N/A0.006%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC393,776$1.79M0.1%+11.8%0.154%Search for SEC Filing on Google Icon
11/13/2023Mariner LLC371,850$1.69M0.0%+107.3%0.145%Search for SEC Filing on Google Icon
11/13/2023Dark Forest Capital Management LP21,792$99K0.0%-40.1%0.009%Search for SEC Filing on Google Icon
11/13/2023Clear Street Markets LLC7,786$35K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/13/2023Rathbones Group PLC71,154$0.32M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/13/2023Rhenman & Partners Asset Management AB950,000$4.32M0.5%+11.8%0.371%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC1,496,170$6.81M0.0%+42.1%0.585%Search for SEC Filing on Google Icon
11/13/2023E Fund Management Co. Ltd.76,850$0.35M0.0%+35.8%0.030%Search for SEC Filing on Google Icon
11/9/2023Rhenman & Partners Asset Management AB35,000$0.16M0.0%-95.9%0.014%Search for SEC Filing on Google Icon
11/9/2023Deutsche Bank AG503,287$2.29M0.0%-84.8%0.203%Search for SEC Filing on Google Icon
11/9/2023Artisan Partners Limited Partnership5,036,479$22.92M0.0%+13.8%2.033%Search for SEC Filing on Google Icon
11/8/2023State Board of Administration of Florida Retirement System65,451$0.30M0.0%+10.8%0.026%Search for SEC Filing on Google Icon
11/8/2023Pathstone Family Office LLC10,519$48K0.0%N/A0.004%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.1,692,533$7.70M0.0%+13.5%0.683%Search for SEC Filing on Google Icon
11/8/2023Swiss National Bank489,356$2.23M0.0%+18.9%0.197%Search for SEC Filing on Google Icon
11/8/2023Amalgamated Bank22,306$0.10M0.0%+24.8%0.009%Search for SEC Filing on Google Icon
11/8/2023J.P. Morgan Private Wealth Advisors LLC31,294$0.14M0.0%+58.4%0.013%Search for SEC Filing on Google Icon
11/8/2023New York Life Investment Management LLC58,273$0.27M0.0%-13.6%0.024%Search for SEC Filing on Google Icon
11/8/2023Pekin Hardy Strauss Inc.56,000$0.26M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/7/2023Great Lakes Advisors LLC276,534$1.26M0.0%-2.7%0.112%Search for SEC Filing on Google Icon
11/7/2023CM Management LLC200,000$0.91M0.9%N/A0.081%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Iovance Biotherapeutics logo
Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma. It also develops lifileucel in combination with pembrolizumab to treat frontline advanced melanoma patients; LN-145 for the treatment of non-small cell lung cancer (NSCLC) and solid tumor cancers; IOV-4001, which is in Phase 1/2 IOV-GM1-201 clinical trial, for the treatment of NSCLC; and lifileucel for gynecological cancers. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
Read More on Iovance Biotherapeutics

Today's Range

Now: $11.24
Low: $11.16
High: $11.58

50 Day Range

MA: $13.96
Low: $9.15
High: $17.47

52 Week Range

Now: $11.24
Low: $3.21
High: $18.33

Volume

250,598 shs

Average Volume

8,444,349 shs

Market Capitalization

$3.14 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62

Who are the company insiders with the largest holdings of Iovance Biotherapeutics?

Iovance Biotherapeutics' top insider shareholders include:
  1. Wayne P Rothbaum (Director)
  2. Merrill A Mcpeak (Director)
  3. Iain D Dukes (Director)
  4. Frederick G Vogt (CEO)
Learn More about top insider investors at Iovance Biotherapeutics.

Who are the major institutional investors of Iovance Biotherapeutics?

Iovance Biotherapeutics' top institutional shareholders include:
  1. Rice Hall James & Associates LLC — 0.61%
  2. Hennion & Walsh Asset Management Inc. — 0.15%
  3. Raymond James Financial Services Advisors Inc. — 0.05%
  4. Grimes & Company Inc. — 0.01%
  5. Diversified Trust Co — 0.01%
Learn More about top institutional investors of Iovance Biotherapeutics stock.

Which major investors are selling Iovance Biotherapeutics stock?

During the last quarter, IOVA stock was sold by these institutional investors:
  1. Rice Hall James & Associates LLC
  2. Grimes & Company Inc.

Which major investors are buying Iovance Biotherapeutics stock?

During the last quarter, IOVA stock was acquired by institutional investors including:
  1. Hennion & Walsh Asset Management Inc.
  2. Raymond James Financial Services Advisors Inc.
  3. Diversified Trust Co
Within the last year, these company insiders have bought Iovance Biotherapeutics stock:
  1. Wayne P Rothbaum (Director)
  2. Merrill A Mcpeak (Director)
  3. Iain D Dukes (Director)
  4. Frederick G Vogt (CEO)
Learn More investors buying Iovance Biotherapeutics stock.
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry